Rolf Richter - Concepedia

Author

Rolf Richter

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Dominique Koensgen-Mustea, R Richter, R. Melvyn Richter, R. Richter, R.H.H. Richter, ROLF RICHTER, Richter R, Richter, Rolf, Rolf Richter

232

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Universität Hamburg University Medical Center Hamburg-Eppendorf Humboldt-Universität zu Berlin Kliniken Essen-Mitte

About

Rolf Richter is an author at Charité - Universitätsmedizin Berlin specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	1.6K
2	Public Health	7	7	581
3	Health Sciences	2	2	150
4	Child Development	2	2	414
5	Biostatistics	1	1	46

Rolf Richter

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast-feeding Karl E. Bergmann, Renate L. Bergmann, Rüdiger von Kries, International Journal of Obesity ObesityNutritionChildhood ObesityInfant NutritionChildhood Overweight	2003	297
Impact of endometriosis on quality of life, anxiety, and depression: an Austrian perspective F. Friedl, David Riedl, S. Fessler, Archives of Gynecology and Obstetrics Quality Of LifeInfertilityGynecological SurgeryPsychiatryEndometriosis	2015	142
Prevalence and risk factors for early postpartum anemia Renate L. Bergmann, Rolf Richter, Karl E. Bergmann, European Journal of Obstetrics & Gynecology and Reproductive Biology Postpartum HemorrhageMaternal ComplicationHematologyGynecologyMaternal Health	2010	132
Secular trends in neonatal macrosomia in Berlin: influences of potential determinants Renate L. Bergmann, Rolf Richter, Karl E. Bergmann, Paediatric and Perinatal Epidemiology NeonatologyFertilityPreterm Birth PredictionSecular TrendHigh-risk Pregnancy	2003	117
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Radoslav Chekerov, Felix Hilpert, Sven� Mahner, The Lancet Oncology OncologyMedicineMetronomic TherapyClinical TrialsGynecology	2018	108
Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy? Renate L. Bergmann, Karl E. Bergmann, Elisabeth Haschke‐Becher, Journal of Perinatal Medicine	2007	101
Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation Christina Fotopoulou, Rongyu Zang, Murat Gültekin, Annals of Surgical Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryTertiary Cytoreductive SurgeryEpithelial Ovarian Cancer	2012	75
Supplementation with 200 mg/Day Docosahexaenoic Acid from Mid-Pregnancy through Lactation Improves the Docosahexaenoic Acid Status of Mothers with a Habitually Low Fish Intake and of Their Infants Renate L. Bergmann, Elisabeth Haschke‐Becher, Petra Klassen-Wigger, Annals of Nutrition and Metabolism	2008	73
Role of secondary cytoreductive surgery in ovarian cancer relapse: Who will benefit? A systematic analysis of 240 consecutive patients Jalid Sehouli, Rolf Richter, Elena Ioana Braicu, Journal of Surgical Oncology	2010	72
Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients Elena Ioana Braicu, Christina Fotopoulou, Toon Van Gorp, Gynecologic Oncology Surgical OncologyMedicineHepatobiliary TumorGynecologyPreoperative He4 Expression	2012	58

Page 1